✦ LIBER ✦

Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor

✍ Scribed by Anand, Ruchi; Maksimoska, Jasna; Pagano, Nicholas; Wong, Eric Y.; Gimotty, Phyllis A.; Diamond, Scott L.; Meggers, Eric; Marmorstein, Ronen

Book ID: 127303987
Publisher: American Chemical Society
Year: 2009
Tongue: English
Weight: 639 KB
Volume: 52
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm8005806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of NS-187, a potent and sele

Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor

✍ Shinya Kimura; Tomoko Niwa; Kazuko Hirabayashi; Taira Maekawa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 381 KB

Pyrimidoaminotropanes as Potent, Selecti

Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR)

✍ Estrada, Anthony A.; Shore, Daniel G.; Blackwood, Elizabeth; Chen, Yung-Hsiang; 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 938 KB

387 The Focal Adhesion Kinase Inhibitor

387 The Focal Adhesion Kinase Inhibitor GSK2256098: a Potent and Selective Inhibitor for the Treatment of Cancer

✍ Auger, K.R.; Smitheman, K.N.; Korenchuk, S.; McHugh, C.; Kruger, R.; Van Aller, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

341 POSTER The discovery of MP529, a pot

341 POSTER The discovery of MP529, a potent and selective aurora kinase inhibitor using CLIMB

✍ H. Vankayalapati; C. Grand; X. Liu; X. Zhang; J. Lamb; M. Lloyd; J. Sunseri; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

437 Biomarker Development for the Pharma

437 Biomarker Development for the Pharmacodynamic Assessment of CC-223, a Potent and Selective mTOR Kinase Inhibitor, in Phase I Clinical Trials

✍ Wong, L.; Liu, Y.; Wu, X.; Bauer, D.; Chen, B.; Hege, K.; Chopra, R.; Bendell, J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

AZD8055 Is a Potent, Selective, and Oral

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity

✍ Chresta, C. M.; Davies, B. R.; Hickson, I.; Harding, T.; Cosulich, S.; Critchlow 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 932 KB